高血压的内分泌原因:文献综述和实践方法
Jean-Baptiste de Freminville1,2, Laurence Amar3,4, Michel Azizi3,4
1Hypertension Unit, AP-HP, Hôpital Européen Georges Pompidou, F-75015, Paris, France. jean.de-freminville@polytechnique.org.
概括
二次高血压,通常是由内分泌问题引起的,影响5-15%的患者. 识别和治疗这些原因可以改善血压控制和减少相关风险.
科学领域:
- 内分泌学 在内分泌学.
- 心血管医学 心血管医学
- 腎臟病學 (nephrology) 是一種醫學專業.
背景情况:
- 高血压 (HTN) 是一个普遍的全球健康问题,影响超过30%的成年人,并作为一个主要的可修改的心血管风险因素.
- 二次性高血压,占病例的5-15%,由可识别的原因引起,与初级高血压不同.
- 二次性HTN与初级HTN相比,与增加的发病率和死亡率有关,这强调了其识别的重要性.
研究的目的:
- 确定二次高血压的内分泌原因.
- 讨论与内分泌相关的二次高血压的潜在治疗方法.
- 突出发现二次性HTN对于改善患者治疗结果的重要性.
主要方法:
- 关于二次高血压的当前医学文献的综述.
- 专注于内分泌病因,包括原发性阿尔多斯特隆症,乳红细胞瘤和库辛综合征.
- 讨论已确定的内分泌原因的诊断标准和治疗策略.
主要成果:
- 主要的阿尔多斯特主义是二次性HTN的最常见的内分泌原因.
- 乳红细胞瘤和库辛综合征是潜在的严重并发症的显著内分泌原因.
- 二次性HTN的早期诊断允许针对性治疗,可能导致治愈和更好的血压管理.
结论:
- 内分泌疾病代表了二次高血压原因的关键类别.
- 根据特定的临床症状和标准,建议对二次性HTN进行查.
- 有效管理二次性HTN,特别是内分泌原因,可以显著改善心血管健康和预后.
相关概念视频
Hypertension III: Clinical Manifestations and Diagnostic Studies
15
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
15
Hypertension and Regulation of Blood Pressure
2.1K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.1K
Hypertension II: Pathophysiology
14
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
14
Hypertension I: Introduction
14
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
14
Hormonal Regulation of Blood Pressure
2.7K
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
2.7K
Hypertension IV: Drug Therapy and Lifestyle Modifications
12
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
12


